AARD
NASD Aardvark Therapeutics, Inc.$3.74 ↑ +0.00 (+0.00%) Trading Up from the previous close of $3.74, $0.31 below the day’s high of $4.05
- YTD change
- -71.50%
- vs 20-day SMA
- -23.94%
- vs 200-day SMA
- -45.82%
Price ranges
Price & Performance
-1.91 (-33.81%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 80.9% away from all-time highs of $19.58
- AARD is down 72% since the beginning of the year
- AARD is down 71% over the past 12 months
- AARD is down 30% over the past 1 month
- 4% of all AARD investors are betting against AARD
AARD reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -69.5%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -21.43%
- vs 8-day SMA
- -13.12%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel, small-molecule therapeutics for the treatment of metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.